Invasion of the basement membrane is believed to be a critical step in the metastatic process.
Melanoma cells have been shown previously to bind distinct triple-helical regions within basement membrane (
type IV) collagen. Additionally,
tumor cell binding sites within
type IV collagen contain
glycosylated hydroxylysine residues. In the present study, we have utilized triple-helical models of the
type IV collagen alpha1(IV)1263-1277 sequence to (a) determine the
melanoma cell receptor for this
ligand and (b) analyze the results of single-site glycosylation on
melanoma cell recognition. Receptor identification was achieved by a combination of methods, including (a) cell adhesion and spreading assays using triple-helical alpha1(IV)1263-1277 and an Asp(1266)Abu variant, (b) inhibition of cell adhesion and spreading assays, and (c) triple-helical alpha1(IV)1263-1277 affinity chromatography with whole cell lysates and
glycosaminoglycans. Triple-helical alpha1(IV)1263-1277 was bound by
melanoma cell CD44/
chondroitin sulfate proteoglycan receptors and not by the
collagen-binding
integrins or
melanoma-associated
proteoglycan.
Melanoma cell adhesion to and spreading on the triple-helical alpha1(IV)1263-1277 sequence was then compared for glycosylated (replacement of Lys(1265) with Hyl(O-beta-d-galactopyranosyl)) versus non-glycosylated
ligand. Glycosylation was found to strongly modulate both activities, as adhesion and spreading were dramatically decreased due to the presence of
galactose. CD44/
chondroitin sulfate proteoglycan did not bind to glycosylated alpha1(IV)1263-1277. Overall, this study (a) is the first demonstration of the prophylactic effects of glycosylation on
tumor cell interaction with the basement membrane, (b) provides a rare example of an apparent unfavorable interaction between
carbohydrates, and (c) suggests that
sugars may mask "cryptic sites" accessible to
tumor cells with cell surface or secreted
glycosidase activities.